Fibromatosis

• Fibromatosis encompasses a rare group of soft tissue tumors arising from fibroblasts.
• These tumors are characterized by local aggressiveness and a tendency to recur, but they do not metastasize.
• Different types exist, including desmoid tumors, infantile fibromatosis, and palmar/plantar fibromatosis, each with distinct presentations.
• Diagnosis typically involves imaging and biopsy to differentiate from other soft tissue lesions.
• Treatment strategies vary based on tumor type, location, and aggressiveness, ranging from watchful waiting to surgery, radiation, or systemic therapies.

What is Fibromatosis?

Fibromatosis refers to a heterogeneous group of rare soft tissue tumors characterized by the uncontrolled proliferation of fibroblasts and myofibroblasts. These tumors are notable for their locally aggressive growth patterns and a high tendency for recurrence after surgical removal, but they are generally considered benign because they do not metastasize (spread to distant parts of the body). The exact cause of fibromatosis is often unknown, though genetic factors and trauma are implicated in some forms. According to the National Cancer Institute, desmoid tumors, a common type of fibromatosis, have an incidence of 2-4 per million people per year, highlighting their rarity.

Types of Fibromatosis: Symptoms and Causes

The diverse nature of fibromatosis is reflected in its various classifications, each presenting with unique characteristics regarding location, age of onset, and underlying causes. Understanding the specific types of fibromatosis is crucial for accurate diagnosis and management. While the overarching characteristic is the fibrous proliferation, the clinical presentation, including fibromatosis symptoms and causes, can differ significantly.

• Desmoid Tumors (Aggressive Fibromatosis): These are perhaps the most well-known type, often occurring in the abdomen, limbs, or chest wall. Symptoms include a palpable mass, pain, and functional impairment if they compress nerves or organs. Causes are often sporadic, but a significant portion is associated with familial adenomatous polyposis (FAP) syndrome due to mutations in the APC gene.
• Infantile Fibromatosis: A rare condition affecting infants and young children, often presenting as a firm, solitary mass in soft tissues, bone, or viscera. The exact cause is unknown, but some cases are linked to specific genetic translocations.
• Palmar Fibromatosis (Dupuytren’s Contracture) and Plantar Fibromatosis (Ledderhose Disease): These involve the fascia of the palms and soles, respectively. Symptoms include thickening and nodule formation, which can lead to contractures (inability to fully extend fingers or toes) in palmar fibromatosis. Causes are multifactorial, involving genetic predisposition, trauma, and certain medical conditions like diabetes or epilepsy.
• Juvenile Hyaline Fibromatosis: An extremely rare, inherited disorder characterized by multiple skin nodules, gingival hypertrophy, and joint contractures. It is caused by mutations in the ANTXR2 gene.

Fibromatosis Treatment Options

Managing fibromatosis requires a multidisciplinary approach tailored to the specific type, location, size, and aggressiveness of the tumor, as well as the patient’s overall health. Given the rarity and variability, there are several fibromatosis treatment options available, ranging from observation to aggressive interventions. The primary goal is to control local disease, alleviate symptoms, and preserve function.

• Watchful Waiting: For asymptomatic, stable, or slowly growing lesions, especially in locations where surgery might cause significant morbidity, observation with regular imaging may be appropriate.
• Surgery: Complete surgical excision with clear margins is often the preferred initial treatment for resectable tumors. However, the high local recurrence rate remains a challenge, and surgery can be complex depending on the tumor’s proximity to vital structures.
• Radiation Therapy: Used alone or in combination with surgery, radiation therapy can help reduce tumor size, control growth, and decrease recurrence rates, particularly for unresectable or recurrent tumors.
• Systemic Therapies: For aggressive or recurrent cases, medical treatments may be considered. These can include chemotherapy, targeted therapies (such as imatinib or sorafenib for specific molecular pathways), and non-steroidal anti-inflammatory drugs (NSAIDs) for pain management and potential anti-proliferative effects.
• Cryoablation or Radiofrequency Ablation: These minimally invasive techniques can be considered for selected tumors, particularly smaller ones or those in difficult-to-reach locations, to destroy tumor cells using extreme cold or heat.

It is important for patients to discuss all potential treatment avenues with their healthcare team to determine the most suitable and effective plan.